These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 431871)

  • 1. [Tumor-causing drugs used in clinical medicine].
    Feo F
    Minerva Med; 1979 Feb; 70(6):503-6. PubMed ID: 431871
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-induced cancer.
    Fraumeni JF; Miller RW
    J Natl Cancer Inst; 1972 May; 48(5):1267-70. PubMed ID: 4555495
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hazards of immunosuppressive agents in general practice].
    Godeau P; Herreman G; Sicard D; de Saxce H
    Rev Prat; 1972 Dec; 22(33):4617-24. PubMed ID: 4660110
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of epidemiology in identifying drugs which may cause malformations--with particular reference to drugs containing sex hormones.
    Kelsey FO
    Acta Morphol Acad Sci Hung; 1980; 28(1-2):189-95. PubMed ID: 7004099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cancer of therapeutic origin].
    Belpomme D; Blondel P; Mathe G
    Vie Med Can Fr; 1972 Feb; 1(2):140-50. PubMed ID: 4637392
    [No Abstract]   [Full Text] [Related]  

  • 6. Steroid hormones and medications that alter cancer risks.
    Thomas DB
    Cancer; 1988 Oct; 62(8 Suppl):1755-67. PubMed ID: 3048637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinogenic effects of anti neoplastic and immunosuppressive drugs].
    Brock N; Schneider B
    Arzneimittelforschung; 1971 Apr; 21(4):435-43. PubMed ID: 5108136
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current trends in the chemotherapy of cancer].
    Silva-Sosa M
    Gac Med Mex; 1974 May; 107(5):469-87. PubMed ID: 4602758
    [No Abstract]   [Full Text] [Related]  

  • 9. Selected problems in immunosuppressive therapy.
    Rondio H
    Mater Med Pol; 1974; 6(1):34-40. PubMed ID: 4613962
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors associated with the use of sex hormones.
    Taylor W
    Anticancer Res; 1987; 7(5B):943-8. PubMed ID: 2829703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive drugs].
    Bratkowska-Seniów B
    Pol Tyg Lek; 1969 May; 24(19):705-7. PubMed ID: 4896203
    [No Abstract]   [Full Text] [Related]  

  • 12. Diethylstilbestrol and other sex hormones during pregnancy.
    Herbst AL
    Obstet Gynecol; 1981 Nov; 58(5 Suppl):35S-40S. PubMed ID: 7031540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in the carcinogenicity of anticancer agents.
    Prejean JD; Montgomery JA
    Drug Metab Rev; 1984; 15(3):619-46. PubMed ID: 6386411
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinogenicity studies in animals relevant to the use of anabolic agents in animal production.
    Rose FJ
    Environ Qual Saf Suppl; 1976; (5):227-37. PubMed ID: 821748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
    Hertz R
    Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
    [No Abstract]   [Full Text] [Related]  

  • 16. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies.
    Abe T; Tsuda S; Maekawa T; Taniwaki M; Sonoda Y; Ide T; Misawa S; Takino T; Inoue K
    Cancer Treat Rep; 1985 May; 69(5):505-14. PubMed ID: 4005873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation antigens and viral carcinogenesis.
    Haughton G; Nash DR
    Prog Med Virol; 1969; 11():248-306. PubMed ID: 4906871
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of immunosuppressive agents on the corneal graft rejection.
    el-Gammal MY; Soliman A el-M ; Mostafa MS
    Bull Ophthalmol Soc Egypt; 1970; 63(67):111-8. PubMed ID: 4938106
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carcinogenic effects of antineoplastic and immunosuppressive agents].
    Brock N; Schneider H
    Arzneimittelforschung; 1971 Sep; 21(9):1406-10. PubMed ID: 5171799
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence of de novo malignancies in renal transplant patients after anti-T-lymphocytic therapy.
    Kosch M; Könecke J; Hausberg M; Kisters K
    Clin Nephrol; 2001 Dec; 56(6):S35-6. PubMed ID: 11770811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.